S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
Is This The Collapse of Icahn Enterprises ?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
20 Best Healthcare Dividend Stocks to Invest in
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
What Does the Airbnb Guidance Drop Say About Travel Demand?
What is the Penalty for Excess Contributions to an IRA?
NASDAQ:IMMP

Immutep (IMMP) Stock Forecast, Price & News

$2.01
0.00 (0.00%)
(As of 06/1/2023 ET)
Compare
Today's Range
$2.01
$2.01
50-Day Range
$1.54
$2.62
52-Week Range
$1.47
$3.90
Volume
N/A
Average Volume
985,869 shs
Market Capitalization
$176.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

Immutep MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
397.5% Upside
$10.00 Price Target
Short Interest
Healthy
0.89% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Immutep in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.38) to ($0.49) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.23 out of 5 stars

Medical Sector

1801st out of 1,980 stocks

Pharmaceutical Preparations Industry

903rd out of 978 stocks


IMMP stock logo

About Immutep (NASDAQ:IMMP) Stock

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.

Receive IMMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immutep and its competitors with MarketBeat's FREE daily newsletter.

IMMP Stock News Headlines

Comparing Immutep (NASDAQ:IMMP) & Vaccitech (NASDAQ:VACC)
Having Trouble in Your Trading?
If you’re having issues in your trading, it could be that it's not you - it really is the market… Well, you’re in control. You can sit on the sideline when it feels right or anticipate massive trend reversals with A.I. like I’ll show you in this upcoming FREE Live A.I. Stock Market Training.
Having Trouble in Your Trading?
If you’re having issues in your trading, it could be that it's not you - it really is the market… Well, you’re in control. You can sit on the sideline when it feels right or anticipate massive trend reversals with A.I. like I’ll show you in this upcoming FREE Live A.I. Stock Market Training.
Immutep to Participate in Two Upcoming Investor Conferences
See More Headlines

IMMP Price History

IMMP Company Calendar

Today
6/01/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IMMP
Employees
2,021
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+397.5%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.90 million
Book Value
$0.79 per share

Miscellaneous

Free Float
85,231,000
Market Cap
$176.74 million
Optionable
Not Optionable
Beta
2.39

Key Executives

  • Marc Voigt
    Chief Executive Officer, CFO & Executive Director
  • Deanne Miller
    COO, Secretary & General Counsel
  • David Fang
    Finance Director & Assistant Secretary
  • Florian D. Vogl
    Chief Medical Officer
  • Christian Mueller
    Vice President-Strategic Development













IMMP Stock - Frequently Asked Questions

What is Immutep's stock price forecast for 2023?

0 equities research analysts have issued twelve-month price targets for Immutep's shares. Their IMMP share price forecasts range from $10.00 to $10.00. On average, they expect the company's share price to reach $10.00 in the next twelve months. This suggests a possible upside of 397.5% from the stock's current price.
View analysts price targets for IMMP
or view top-rated stocks among Wall Street analysts.

How have IMMP shares performed in 2023?

Immutep's stock was trading at $1.75 on January 1st, 2023. Since then, IMMP shares have increased by 14.9% and is now trading at $2.01.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Immutep own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immutep investors own include Nuwellis (CHFS), MEI Pharma (MEIP), VBI Vaccines (VBIV), Vaxart (VXRT), Amarin (AMRN), Gilead Sciences (GILD), Heat Biologics (HTBX), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE) and Vascular Biogenics (VBLT).

What is Immutep's stock symbol?

Immutep trades on the NASDAQ under the ticker symbol "IMMP."

Who are Immutep's major shareholders?

Immutep's stock is owned by a variety of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (0.09%), Susquehanna International Group LLP (0.00%), Group One Trading L.P. (0.00%) and Simplex Trading LLC (0.00%).

How do I buy shares of Immutep?

Shares of IMMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Immutep's stock price today?

One share of IMMP stock can currently be purchased for approximately $2.01.

How much money does Immutep make?

Immutep (NASDAQ:IMMP) has a market capitalization of $176.74 million and generates $4.90 million in revenue each year.

How many employees does Immutep have?

The company employs 2,021 workers across the globe.

How can I contact Immutep?

Immutep's mailing address is LEVEL 12 95 PITT STREET, SYDNEY C3, 2000. The official website for the company is www.immutep.com. The biotechnology company can be reached via phone at (128) 315-7003, via email at jay.campbell@immutep.com, or via fax at 61-2-8569-1880.

This page (NASDAQ:IMMP) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -